ADC Medical Safety and Pharmacovigilance

Because ADC patient safety requires focused oversight ADC Medical Safety and Pharmacovigilance

When ADC safety expertise is critical and internal capacity is limited, DES Pharma acts as a trusted extension of your team. We support medical safety leadership, pharmacovigilance oversight, and risk management across development and post-approval stages, with attention to the safety issues most relevant to antibody-drug conjugates.

Phase 1/2:

Proactive ADC safety monitoring, signal detection, risk characterization, and dose-management support during early development.

Phase 3/Post-Authorization

Late-stage and post-approval safety oversight that supports benefit-risk evaluation, regulator expectations, and long-term product use.

 

Pharmacovigilance

Global ADC pharmacovigilance support designed for compliant, inspection-ready operations across the product lifecycle, from case handling through governance and system oversight.

Our team combines medical judgment, pharmacovigilance oversight, and practical ADC development experience to support safer decisions across the product lifecycle.

Get Started Advance Your Drug Program
with Confidence

Start building reliable, high-quality drug development programs today.